Initiated a long - possible 10% to 14% upside short term - looking at $88 maybe higher
GILD is getting net new committed business (orders) from outside the US market for Remdesivir
will feel much better once GILD clears the red zone - a retest into that zone won't be a very good sign.
GILD is getting net new committed business (orders) from outside the US market for Remdesivir
will feel much better once GILD clears the red zone - a retest into that zone won't be a very good sign.